Going further and analyzing Indian market, so far Hyderabad is considered as a key location for the drug manufacturing and Clinical/Contract Research with a majority of units located in and around this city in the south central part of the country. But as of now companies are shifting there focus to other regions also and wants to exploit better opportunities available in other parts of the country as well.
Northern India being an emerging market, companies face a number of unique hurdles and often gets perplexed before entering this lucrative region. As North India is most sought after market theses days,this articles explores scope and feasibility of pharmaceutical,CRO(Clinical/Contract Research Organization) and biotechnology market, and answers the following key questions:
Who are the key players in the Northern India CRO market?
Regulations environment in northern India ?
The scenario of super specialty hospitals and pool of trained investigators ?
Opportunities available in Northern India for conducting clinical trials ?
How can companies engage with India for collaboration ?
Literally speaking Contract...